Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Baroletti

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Circulation|March 31, 2010
Medication adherence in cardiovascular diseaseSteven Baroletti, Heather Dell'Orfano
Critical Pathways in Cardiology|March 15, 2008
PIES method of critiqueSteven Baroletti, Paul M Szumita
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 13, 2002
Visual compatibility of abciximab with selected drugsSteven Baroletti, Christian Hartman, William Churchill
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Treating gout in kidney transplant recipientsSteven Baroletti, Gina Ann Bencivenga, Steven Gabardi
Critical Pathways in Cardiology|June 4, 2010
Dronedarone: a review of characteristics and clinical dataSteven Baroletti, Jennifer Catella, Michael Ehle, et al.
Currents in Pharmacy Teaching & Learning|May 17, 2018
Journal Club Standardization Tool: Helping participants get the JISTMary P Kovacevic, Steven Baroletti, Suzanne M Galal, et al.
Thrombosis and Haemostasis|June 4, 2009
Prescription of fondaparinux in hospitalised patientsSteven Baroletti, Matthew Labreche, Matthew Niles, et al.
The American Journal of Cardiology|October 24, 2007
Adverse drug events in hospitalized cardiac patientsJohn Fanikos, Jennifer L Cina, Steven Baroletti, et al.
Thrombosis and Haemostasis|January 10, 2009
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomesSteven Baroletti, Chiara Piovella, John Fanikos, et al.
The American Journal of Medicine|November 15, 2011
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levelsSteven Baroletti, Shelley Hurwitz, Nicole A S Conti, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Circulation|March 31, 2010
Medication adherence in cardiovascular diseaseSteven Baroletti, Heather Dell'Orfano
Critical Pathways in Cardiology|March 15, 2008
PIES method of critiqueSteven Baroletti, Paul M Szumita
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 13, 2002
Visual compatibility of abciximab with selected drugsSteven Baroletti, Christian Hartman, William Churchill
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Treating gout in kidney transplant recipientsSteven Baroletti, Gina Ann Bencivenga, Steven Gabardi
Critical Pathways in Cardiology|June 4, 2010
Dronedarone: a review of characteristics and clinical dataSteven Baroletti, Jennifer Catella, Michael Ehle, et al.
Currents in Pharmacy Teaching & Learning|May 17, 2018
Journal Club Standardization Tool: Helping participants get the JISTMary P Kovacevic, Steven Baroletti, Suzanne M Galal, et al.
Thrombosis and Haemostasis|June 4, 2009
Prescription of fondaparinux in hospitalised patientsSteven Baroletti, Matthew Labreche, Matthew Niles, et al.
The American Journal of Cardiology|October 24, 2007
Adverse drug events in hospitalized cardiac patientsJohn Fanikos, Jennifer L Cina, Steven Baroletti, et al.
Thrombosis and Haemostasis|January 10, 2009
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomesSteven Baroletti, Chiara Piovella, John Fanikos, et al.
The American Journal of Medicine|November 15, 2011
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levelsSteven Baroletti, Shelley Hurwitz, Nicole A S Conti, et al.
Pageof 2